Form D · Biotechnology
RayMed, LLC
Wichita, KS · CIK 0001687021
Offering snapshot reported Oct 12, 2016 · SEC filing
- Reported sold
- $265K Offering amount: $750K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Sep 10, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2016 | Initial | $265,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-272275
Source: Form D, filed Oct 12, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rachel M. Wykes | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
257 S. Holyoke Street
Wichita, KS, 67218
Wichita, KS, 67218